Akèy › Lukemi miyoyid nan faz kwonik › Oregon
Etid klinik pou Lukemi miyoyid nan faz kwonik nan Oregon
4 etid pou Lukemi miyoyid nan faz kwonik ap chèche patisipan nan sit nan Oregon.
Vil nan Oregon
Tèks ofisyèl etid la (Anglè)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1139, Portland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Oregon Oncology Specialists Salem, Salem
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Jul 20, 2026 · NCT07091019A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Oregon Health & Science University-Knight Cardiovascular Institute, Portland
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 1, 2026 · NCT05304377A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Willamette Valley Cancer Institute and Research Center, Eugene
- Oregon Health & Science University, Portland
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT06163430Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.